| Overview |
| bs-43042p-100ug |
| Recombinant SARS-COV-2 Spike S1 protein, C-His |
| ELISA |
| Others |
| Specifications |
| Unconjugated |
| Recombinant SARS-COV-2 Spike S1 protein, C-His protein is expressed in HEK293 with C-His. It contains the amino acid sequence of 14-685/1273. |
| 0.01M TBS(pH7.4) |
| The product should be stored at -70°C or -20°C. |
| Target |
| 43740568 |
| P0DTC2 |
| The SARS-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |